Pediatric Drug Adherence and Parental Attention: Evidence from Comprehensive Claims Data
Working Paper 30968
DOI 10.3386/w30968
Issue Date
Revision Date
Using comprehensive U.S. drug claims data, we show that pediatric drug adherence declined during the COVID-19 pandemic. Focusing on asthma, we find that young children exhibited a 40 percent decrease in adherence by the end of 2020. The responses were less negative for older children and positive for adults. We provide evidence that parental attention played a key role in driving this decrease, even accounting for air quality changes, school closures, and other socioeconomic and COVID-related factors. Policy implications for future macroeconomic shocks are discussed.